BACKGROUND: Human leukocyte antigen (HLA) supertypes are groups of functionally related alleles that present structurally similar antigens to the immune system. OBJECTIVES: To analyze HLA class I supertype associations with clinical outcome in hospitalized Thai children with acute dengue illness. METHODS: Seven hundred sixty-two patients and population-matched controls recruited predominantly in Bangkok were HLA-A and -B typed. HLA supertype frequencies were compared and tested for significant dengue disease associations using logistic regression analyses. Multivariable models were built by conducting forward stepwise selection procedures. RESULTS: In the final logistic regression model, the HLA-B44 supertype was protective against dengue hemorrhagic fever (DHF) in secondary infections (odds ratio [OR] = 0.46, 95% confidence interval [CI], .30-.72), while the HLA-A02 supertype (OR = 1.92, 95% CI, 1.30-2.83) and the HLA-A01/03 supertype (OR = 3.01, 95% CI, 1.01-8.92) were associated with susceptibility to secondary dengue fever. The B07 supertype was associated with susceptibility to secondary DHF in the univariate analysis (OR = 1.60, 95% CI, 1.05-2.46), whereas that was not retained in the final model. CONCLUSIONS: As the HLA-B44 supertype is predicted to target conserved epitopes in dengue, our results suggest that B44 supertype-restricted immune responses to highly conserved regions of the dengue proteome may protect against secondary DHF.
BACKGROUND:Human leukocyte antigen (HLA) supertypes are groups of functionally related alleles that present structurally similar antigens to the immune system. OBJECTIVES: To analyze HLA class I supertype associations with clinical outcome in hospitalized Thai children with acute dengue illness. METHODS: Seven hundred sixty-two patients and population-matched controls recruited predominantly in Bangkok were HLA-A and -B typed. HLA supertype frequencies were compared and tested for significant dengue disease associations using logistic regression analyses. Multivariable models were built by conducting forward stepwise selection procedures. RESULTS: In the final logistic regression model, the HLA-B44 supertype was protective against dengue hemorrhagic fever (DHF) in secondary infections (odds ratio [OR] = 0.46, 95% confidence interval [CI], .30-.72), while the HLA-A02 supertype (OR = 1.92, 95% CI, 1.30-2.83) and the HLA-A01/03 supertype (OR = 3.01, 95% CI, 1.01-8.92) were associated with susceptibility to secondary dengue fever. The B07 supertype was associated with susceptibility to secondary DHF in the univariate analysis (OR = 1.60, 95% CI, 1.05-2.46), whereas that was not retained in the final model. CONCLUSIONS: As the HLA-B44 supertype is predicted to target conserved epitopes in dengue, our results suggest that B44 supertype-restricted immune responses to highly conserved regions of the dengue proteome may protect against secondary DHF.
Authors: D Chandanayingyong; H A Stephens; R Klaythong; M Sirikong; S Udee; P Longta; R Chantangpol; S Bejrachandra; E Rungruang Journal: Hum Immunol Date: 1997-04-01 Impact factor: 2.850
Authors: E Mackow; Y Makino; B T Zhao; Y M Zhang; L Markoff; A Buckler-White; M Guiler; R Chanock; C J Lai Journal: Virology Date: 1987-08 Impact factor: 3.616
Authors: K Cao; A M Moormann; K E Lyke; C Masaberg; O P Sumba; O K Doumbo; D Koech; A Lancaster; M Nelson; D Meyer; R Single; R J Hartzman; C V Plowe; J Kazura; D L Mann; M B Sztein; G Thomson; M A Fernández-Viña Journal: Tissue Antigens Date: 2004-04
Authors: Derek A T Cummings; Rafael A Irizarry; Norden E Huang; Timothy P Endy; Ananda Nisalak; Kumnuan Ungchusak; Donald S Burke Journal: Nature Date: 2004-01-22 Impact factor: 49.962
Authors: Aleksandr Lazaryan; Tao Wang; Stephen R Spellman; Hai-Lin Wang; Joseph Pidala; Taiga Nishihori; Medhat Askar; Richard Olsson; Machteld Oudshoorn; Hisham Abdel-Azim; Agnes Yong; Manish Gandhi; Christopher Dandoy; Bipin Savani; Gregory Hale; Kristin Page; Menachem Bitan; Ran Reshef; William Drobyski; Steven Ge Marsh; Kirk Schultz; Carlheinz R Müller; Marcelo A Fernandez-Viña; Michael R Verneris; Mary M Horowitz; Mukta Arora; Daniel J Weisdorf; Stephanie J Lee Journal: Haematologica Date: 2016-05-31 Impact factor: 9.941
Authors: Panpimon Luangtrakool; Sasijit Vejbaesya; Komon Luangtrakool; Somporn Ngamhawornwong; Kusuma Apisawes; Siripen Kalayanarooj; Louis R Macareo; Stefan Fernandez; Richard G Jarman; Robert W M Collins; Steven T Cox; Anon Srikiatkhachorn; Alan L Rothman; Henry A F Stephens Journal: J Infect Dis Date: 2020-08-04 Impact factor: 5.226
Authors: Abigail Culshaw; Kristin Ladell; Stephanie Gras; James E McLaren; Kelly L Miners; Carine Farenc; Heleen van den Heuvel; Emma Gostick; Wanwisa Dejnirattisai; Apirath Wangteeraprasert; Thaneeya Duangchinda; Pojchong Chotiyarnwong; Wannee Limpitikul; Sirijitt Vasanawathana; Prida Malasit; Tao Dong; Jamie Rossjohn; Juthathip Mongkolsapaya; David A Price; Gavin R Screaton Journal: Nat Immunol Date: 2017-09-25 Impact factor: 25.606
Authors: E Townsley; G O'Connor; C Cosgrove; M Woda; M Co; S J Thomas; S Kalayanarooj; I-K Yoon; A Nisalak; A Srikiatkhachorn; S Green; H A F Stephens; E Gostick; D A Price; M Carrington; G Alter; D W McVicar; A L Rothman; A Mathew Journal: Clin Exp Immunol Date: 2015-11-24 Impact factor: 4.330
Authors: Anna Foix; Daniel López; Francisco Díez-Fuertes; Michael J McConnell; Antonio J Martín-Galiano Journal: PLoS Comput Biol Date: 2022-02-10 Impact factor: 4.475